A Cancer Research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-003-0733-6 ◽

2004 ◽

Vol 53 (4) ◽

pp. 341-348 ◽

Author(s):

L. A. Gumbrell ◽

T. R. J. Evans ◽

R. E. Coleman ◽

I. E. Smith ◽

C. J. Twelves ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Metastatic Breast ◽

Randomized Phase Ii

Download Full-text

Randomized phase II study of capecitabine with or without ramucirumab (IMC-1121B) or IMC-18F1 in patients with unresectable, locally advanced or metastatic breast cancer (mBC) previously treated with anthracycline and taxane therapy (CP20-0903/NCT01234402).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.tps151 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. TPS151-TPS151 ◽

Author(s):

L. T. Vahdat ◽

K. Miller ◽

J. A. Sparano ◽

H. Youssoufian ◽

J. D. Schwartz ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Metastatic Breast ◽

Randomized Phase Ii ◽

Previously Treated

Download Full-text

Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer

The Oncologist ◽

10.1634/theoncologist.2016-0265 ◽

2017 ◽

Vol 22 (3) ◽

pp. 245-254 ◽

Author(s):

Linda T. Vahdat ◽

Rachel Layman ◽

Denise A. Yardley ◽

William Gradishar ◽

Mohamad A. Salkeni ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Metastatic Breast ◽

Randomized Phase Ii ◽

Previously Treated

Download Full-text

Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study

Annals of Oncology ◽

10.1093/annonc/mdx505 ◽

2018 ◽

Vol 29 (1) ◽

pp. 154-161 ◽

Author(s):

H.S. Han ◽

V. Diéras ◽

M. Robson ◽

M. Palácová ◽

P.K. Marcom ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Randomized Phase Ii ◽

Locally Recurrent

Download Full-text

Randomized phase II study of single-agent epirubicin +/— verapamil in patients with advanced metastatic breast cancer

Annals of Oncology ◽

10.1093/oxfordjournals.annonc.a058356 ◽

1993 ◽

Vol 4 (1) ◽

pp. 45-50 ◽

Author(s):

K. Mross ◽

C. Bohn ◽

L. Edler ◽

W. Jonat ◽

W. Queisser ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Single Agent ◽

Metastatic Breast ◽

Randomized Phase Ii

Download Full-text

START: A randomized phase II study in patients with triple negative, androgen receptor positive locally recurrent (unresectable) or metastatic breast cancer treated with darolutamide or capecitabine (UCBG-306)

Annals of Oncology ◽

10.1093/annonc/mdy272.356 ◽

2018 ◽

Vol 29 ◽

pp. viii120 ◽

Author(s):

H. Bonnefoi ◽

C. Levy ◽

G. MacGrogan ◽

T. Grellety ◽

B. Asselain ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Androgen Receptor ◽

Phase Ii ◽

Triple Negative ◽

Phase Ii Study ◽

Metastatic Breast ◽

Randomized Phase Ii ◽

Locally Recurrent

Download Full-text

Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group study

British Journal of Cancer ◽

10.1038/sj.bjc.6601840 ◽

2004 ◽

Vol 90 (11) ◽

pp. 2131-2134 ◽

Author(s):

A C Humphreys ◽

J Dent ◽

S Rodwell ◽

S M Crawford ◽

J K Joffe ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Research Group ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Research ◽

Venous Infusion

Download Full-text

P5-19-02: Comparison of the Incidence of Peripheral Neuropathy with Eribulin Mesylate Versus Ixabepilone in Metastatic Breast Cancer Patients: A Randomized Phase II Study.

10.1158/0008-5472.sabcs11-p5-19-02 ◽

2011 ◽

Author(s):

L Vahdat ◽

P Gopalakrishna ◽

AA Garcia ◽

C Vogel ◽

C Pellegrino ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Peripheral Neuropathy ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Eribulin Mesylate ◽

Randomized Phase Ii

Download Full-text

Abstract GS2-07: MANTA - A randomized phase II study of fulvestrant in combination with the dual mTOR inhibitor AZD2014 or everolimus or fulvestrant alone in estrogen receptor-positive advanced or metastatic breast cancer

10.1158/1538-7445.sabcs17-gs2-07 ◽

2018 ◽

Author(s):

P Schmid ◽

M Zaiss ◽

C Harper-Wynne ◽

M Ferreira ◽

S Dubey ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Mtor Inhibitor ◽

Phase Ii Study ◽

Metastatic Breast ◽

Randomized Phase Ii ◽

Estrogen Receptor Positive

Download Full-text

Abstract PD1-10: Randomized phase II study comparing two different schedules of palbociclib plus second line endocrine therapy in women with estrogen receptor positive, HER2 negative advanced/metastatic breast cancer: CCTG MA38 (NCT02630693)

10.1158/1538-7445.sabcs18-pd1-10 ◽

2019 ◽

Author(s):

WR Parulekar ◽

AA Joy ◽

K Gelmon ◽

M Mates ◽

C Desbiens ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Metastatic Breast Cancer ◽

Endocrine Therapy ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Second Line ◽

Randomized Phase Ii ◽

Estrogen Receptor Positive

Download Full-text

A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA)

Anti-Cancer Drugs ◽

10.1097/cad.0000000000000722 ◽

2019 ◽

Vol 30 (4) ◽

pp. 394-401

Author(s):

Joachim Bischoff ◽

Jana Barinoff ◽

Christoph Mundhenke ◽

Dirk O. Bauerschlag ◽

Serban-Dan Costa ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Randomized Phase Ii ◽

Pretreated Patients ◽

Download Full-text